{"id":2708,"date":"2020-10-03T11:50:24","date_gmt":"2020-10-03T11:50:24","guid":{"rendered":"http:\/\/amaderbrahmanbaria.xyz\/en\/?p=2708"},"modified":"2020-10-03T11:50:24","modified_gmt":"2020-10-03T11:50:24","slug":"german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/","title":{"rendered":"German authorities approve 3rd clinical trial of COVID-19 vaccine"},"content":{"rendered":"<p>Paul-Ehrlich-Institut (PEI), Germany&#8217;s Federal Institute for Vaccines and Biomedicines, has approved the third clinical trial of a potential COVID-19 vaccine.<\/p>\n<p>&#8220;Trials on vaccine candidates in humans are a significant step in the direction of authorizing safe and efficacious vaccines against COVID-19,&#8221; PEI noted.<\/p>\n<p>The vaccine candidate was developed by the German Center for Infection Research (DZIF) and the pharmaceutical company IDT Biologika.<\/p>\n<p>During the Phase-1 trial, 30 healthy adult volunteers between 18 and 55 years would receive two vaccinations at a four-week interval, according to PEI.<\/p>\n<p>The candidate is a vector vaccine for which the genetic information for a surface protein of SARS-CoV-2 is built into a smallpox virus, according to PEI.<\/p>\n<p>The vaccine against the smallpox virus had already been developed more than 30 years ago at the Ludwig-Maximilians-University Munich (LMU).<\/p>\n<p>The vector could not replicate in the body of the vaccinated person, but the genetic information introduced could simulate an infection and trigger the production of COVID-19 antibodies and immune cells.<\/p>\n<p>Also read: Investigational COVID-19 vaccine well-tolerated: study<\/p>\n<p>The German government launched a special funding program to accelerate research and development of a COVID-19 vaccine, with up to 750 million euros (878 million U.S. dollars).<\/p>\n<p>The clinical trial of the vaccine candidate by IDT Biologika and DZIF is one of three trials currently conducted by German companies in the fight against COVID-19.<\/p>\n<p>The pharmaceutical companies BioNTech and CureVac are already conducting studies in advanced phases in trials on humans.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Paul-Ehrlich-Institut (PEI), Germany&#8217;s Federal Institute for Vaccines and Biomedicines, has approved the third clinical trial of a potential COVID-19 vaccine. &#8220;Trials on vaccine candidates in humans are a significant step in the direction of authorizing safe and efficacious vaccines against COVID-19,&#8221; PEI noted. The vaccine candidate was developed by the German Center for Infection Research &hellip; <a href=\"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">German authorities approve 3rd clinical trial of COVID-19 vaccine<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":5,"featured_media":2709,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,33],"tags":[],"class_list":["post-2708","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-international","category-slider"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>German authorities approve 3rd clinical trial of COVID-19 vaccine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"German authorities approve 3rd clinical trial of COVID-19 vaccine\" \/>\n<meta property=\"og:description\" content=\"Paul-Ehrlich-Institut (PEI), Germany&#8217;s Federal Institute for Vaccines and Biomedicines, has approved the third clinical trial of a potential COVID-19 vaccine. &#8220;Trials on vaccine candidates in humans are a significant step in the direction of authorizing safe and efficacious vaccines against COVID-19,&#8221; PEI noted. The vaccine candidate was developed by the German Center for Infection Research &hellip; Continue reading German authorities approve 3rd clinical trial of COVID-19 vaccine &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/\" \/>\n<meta property=\"og:site_name\" content=\"Amader Brahmanbaria - Most Reading Online Porotal In Brahmanbaria\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-03T11:50:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/amaderbrahmanbaria.com\/en\/wp-content\/uploads\/2020\/10\/Chinese_vaccine.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Manik Hossain\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Manik Hossain\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/2020\\\/10\\\/03\\\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/2020\\\/10\\\/03\\\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\\\/\"},\"author\":{\"name\":\"Manik Hossain\",\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/#\\\/schema\\\/person\\\/16c0a46895e1b14d4ec9da756e038203\"},\"headline\":\"German authorities approve 3rd clinical trial of COVID-19 vaccine\",\"datePublished\":\"2020-10-03T11:50:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/2020\\\/10\\\/03\\\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\\\/\"},\"wordCount\":246,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/2020\\\/10\\\/03\\\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/Chinese_vaccine.jpg\",\"articleSection\":[\"International\",\"slider\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/2020\\\/10\\\/03\\\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/2020\\\/10\\\/03\\\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\\\/\",\"url\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/2020\\\/10\\\/03\\\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\\\/\",\"name\":\"German authorities approve 3rd clinical trial of COVID-19 vaccine\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/2020\\\/10\\\/03\\\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/2020\\\/10\\\/03\\\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/Chinese_vaccine.jpg\",\"datePublished\":\"2020-10-03T11:50:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/#\\\/schema\\\/person\\\/16c0a46895e1b14d4ec9da756e038203\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/2020\\\/10\\\/03\\\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/2020\\\/10\\\/03\\\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/2020\\\/10\\\/03\\\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\\\/#primaryimage\",\"url\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/Chinese_vaccine.jpg\",\"contentUrl\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/Chinese_vaccine.jpg\",\"width\":800,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/2020\\\/10\\\/03\\\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"German authorities approve 3rd clinical trial of COVID-19 vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/\",\"name\":\"Amader Brahmanbaria - Most Reading Online Porotal In Brahmanbaria\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/#\\\/schema\\\/person\\\/16c0a46895e1b14d4ec9da756e038203\",\"name\":\"Manik Hossain\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4945fdf5f1322e72fba6ca6f0d96ad12457d783c634dfa5da03c7b355430e097?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4945fdf5f1322e72fba6ca6f0d96ad12457d783c634dfa5da03c7b355430e097?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4945fdf5f1322e72fba6ca6f0d96ad12457d783c634dfa5da03c7b355430e097?s=96&d=mm&r=g\",\"caption\":\"Manik Hossain\"},\"sameAs\":[\"https:\\\/\\\/amaderbrahmanbaria.xyz\\\/en\\\/\"],\"url\":\"https:\\\/\\\/amaderbrahmanbaria.com\\\/en\\\/author\\\/manik\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"German authorities approve 3rd clinical trial of COVID-19 vaccine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/","og_locale":"en_US","og_type":"article","og_title":"German authorities approve 3rd clinical trial of COVID-19 vaccine","og_description":"Paul-Ehrlich-Institut (PEI), Germany&#8217;s Federal Institute for Vaccines and Biomedicines, has approved the third clinical trial of a potential COVID-19 vaccine. &#8220;Trials on vaccine candidates in humans are a significant step in the direction of authorizing safe and efficacious vaccines against COVID-19,&#8221; PEI noted. The vaccine candidate was developed by the German Center for Infection Research &hellip; Continue reading German authorities approve 3rd clinical trial of COVID-19 vaccine &rarr;","og_url":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/","og_site_name":"Amader Brahmanbaria - Most Reading Online Porotal In Brahmanbaria","article_published_time":"2020-10-03T11:50:24+00:00","og_image":[{"width":800,"height":450,"url":"https:\/\/amaderbrahmanbaria.com\/en\/wp-content\/uploads\/2020\/10\/Chinese_vaccine.jpg","type":"image\/jpeg"}],"author":"Manik Hossain","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Manik Hossain","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/#article","isPartOf":{"@id":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/"},"author":{"name":"Manik Hossain","@id":"https:\/\/amaderbrahmanbaria.com\/en\/#\/schema\/person\/16c0a46895e1b14d4ec9da756e038203"},"headline":"German authorities approve 3rd clinical trial of COVID-19 vaccine","datePublished":"2020-10-03T11:50:24+00:00","mainEntityOfPage":{"@id":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/"},"wordCount":246,"commentCount":0,"image":{"@id":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/#primaryimage"},"thumbnailUrl":"https:\/\/amaderbrahmanbaria.com\/en\/wp-content\/uploads\/2020\/10\/Chinese_vaccine.jpg","articleSection":["International","slider"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/","url":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/","name":"German authorities approve 3rd clinical trial of COVID-19 vaccine","isPartOf":{"@id":"https:\/\/amaderbrahmanbaria.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/#primaryimage"},"image":{"@id":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/#primaryimage"},"thumbnailUrl":"https:\/\/amaderbrahmanbaria.com\/en\/wp-content\/uploads\/2020\/10\/Chinese_vaccine.jpg","datePublished":"2020-10-03T11:50:24+00:00","author":{"@id":"https:\/\/amaderbrahmanbaria.com\/en\/#\/schema\/person\/16c0a46895e1b14d4ec9da756e038203"},"breadcrumb":{"@id":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/#primaryimage","url":"https:\/\/amaderbrahmanbaria.com\/en\/wp-content\/uploads\/2020\/10\/Chinese_vaccine.jpg","contentUrl":"https:\/\/amaderbrahmanbaria.com\/en\/wp-content\/uploads\/2020\/10\/Chinese_vaccine.jpg","width":800,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/amaderbrahmanbaria.com\/en\/2020\/10\/03\/german-authorities-approve-3rd-clinical-trial-of-covid-19-vaccine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/amaderbrahmanbaria.com\/en\/"},{"@type":"ListItem","position":2,"name":"German authorities approve 3rd clinical trial of COVID-19 vaccine"}]},{"@type":"WebSite","@id":"https:\/\/amaderbrahmanbaria.com\/en\/#website","url":"https:\/\/amaderbrahmanbaria.com\/en\/","name":"Amader Brahmanbaria - Most Reading Online Porotal In Brahmanbaria","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/amaderbrahmanbaria.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/amaderbrahmanbaria.com\/en\/#\/schema\/person\/16c0a46895e1b14d4ec9da756e038203","name":"Manik Hossain","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4945fdf5f1322e72fba6ca6f0d96ad12457d783c634dfa5da03c7b355430e097?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4945fdf5f1322e72fba6ca6f0d96ad12457d783c634dfa5da03c7b355430e097?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4945fdf5f1322e72fba6ca6f0d96ad12457d783c634dfa5da03c7b355430e097?s=96&d=mm&r=g","caption":"Manik Hossain"},"sameAs":["https:\/\/amaderbrahmanbaria.xyz\/en\/"],"url":"https:\/\/amaderbrahmanbaria.com\/en\/author\/manik\/"}]}},"_links":{"self":[{"href":"https:\/\/amaderbrahmanbaria.com\/en\/wp-json\/wp\/v2\/posts\/2708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amaderbrahmanbaria.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amaderbrahmanbaria.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amaderbrahmanbaria.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/amaderbrahmanbaria.com\/en\/wp-json\/wp\/v2\/comments?post=2708"}],"version-history":[{"count":1,"href":"https:\/\/amaderbrahmanbaria.com\/en\/wp-json\/wp\/v2\/posts\/2708\/revisions"}],"predecessor-version":[{"id":2710,"href":"https:\/\/amaderbrahmanbaria.com\/en\/wp-json\/wp\/v2\/posts\/2708\/revisions\/2710"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/amaderbrahmanbaria.com\/en\/wp-json\/wp\/v2\/media\/2709"}],"wp:attachment":[{"href":"https:\/\/amaderbrahmanbaria.com\/en\/wp-json\/wp\/v2\/media?parent=2708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amaderbrahmanbaria.com\/en\/wp-json\/wp\/v2\/categories?post=2708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amaderbrahmanbaria.com\/en\/wp-json\/wp\/v2\/tags?post=2708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}